BioNexus Gene Lab Corp Common stock Free Cash Flow Generation Index
BioNexus Gene Lab Corp Common stock free cash flow generation index. BioNexus Gene Lab Corp Common stock (BGLC) has a Free Cash Flow Generation Index of 0.96x as of December 2022. Free cash flow of $457.44K represents 1% of operating cash flow ($474.47K).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of BioNexus Gene Lab Corp Common stock (2017–2022)
Free cash flow generation index of BioNexus Gene Lab Corp Common stock from 2017 to 2022. Historical FCF Generation Index trend for BioNexus Gene Lab Corp Common stock across 4 annual periods. See BioNexus Gene Lab Corp Common stock free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
BioNexus Gene Lab Corp Common stock Free Cash Flow Generation Index by Year (2017–2022)
BioNexus Gene Lab Corp Common stock free cash flow generation index by year from 2017 to 2022. Year-by-year Free Cash Flow Generation Index for BioNexus Gene Lab Corp Common stock. For the full cash flow conversion analysis, see BioNexus Gene Lab Corp Common stock cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.90x | $489.86K | $544.03K | $54.17K | ▲ +37.5% |
| 2021 | 0.65x | $6.00K | $9.16K | $3.16K | ▲ +176.1% |
| 2020 | 0.24x | $131.06K | $552.68K | $421.62K | ▲ +99.8% |
| 2017 | 0.12x | $42.40K | $357.22K | $314.82K | — |